Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Five mega projects to help reposition the UFS
2008-02-01

The University of the Free State (UFS) today announced that it will focus on five mega-projects to help reposition the UFS in the next five years as one of South Africa’s leading universities that is successfully managing excellence and diversity.

Speaking at the official opening of the university today, the Rector and Vice-Chancellor, Prof. Frederick Fourie, identified the five mega projects as:

  • The successful implementation of strategic academic clusters to focus the teaching and research expertise of the UFS.
  • The development and implementation of new models of teaching and learning.
  • Finding new sources of income (including third-stream income) to minimise dependence on government subsidies and tuition fees.
  • Creating a new institutional culture for the university by finalising the Institutional Charter.
  • The ongoing transformation of the UFS in all its dimensions.

According to Prof. Fourie, the strategic clusters – initiated in 2006 – are a very important initiative which is aimed at making the UFS a world leader in six broad areas. The focus of the six clusters has now been determined. These clusters are not just research based, but will include postgraduate programmes and filter down to undergraduate learning programmes and curricula.

He also indicated that other research at the UFS will continue to be supported and funded as before.

The second project, to establish a new teaching and learning model, is meant to address current success rates which indicate the need for this issue to receive a high priority.

New income streams to enable higher levels of financial sustainability is the third project, especially in view of dwindling government subsidies and limits on student numbers. This is necessary to fund sustained higher levels of investment in the quality of academic activities and in the necessary capacity and facilities.

Prof. Fourie said the fourth project regarding institutional culture is an ongoing effort to create a sense of belonging for all staff and students at the UFS through the adoption of an Institutional Charter for the university.

“What the draft Charter does – in addition to describing overarching values espoused by the institution and its people – is to describe the outlines and constitutive principles of the ‘post-redress’ UFS,” said Prof. Fourie.

The Charter – initially launched in 2007 – is and remains a critical element of guiding transformation effectively and speedily towards a widely-accepted goal. It is a critical element of the “social sustainability and robustness” of a new UFS, especially in tumultuous political times.

The fifth project is the Transformation Plan, launched in 2007. “We simply must pursue this plan diligently, given our commitment to comprehensive and deep transformation, and to best practice transformation. All universities will have to face up to the challenge of transformation and the UFS can break new ground, as it did in the past by managing transformation innovatively and creating a campus where all can find their rightful place,” said Prof. Fourie.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
1 February 2008
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept